000 | 01340 a2200361 4500 | ||
---|---|---|---|
005 | 20250514182757.0 | ||
264 | 0 | _c20040506 | |
008 | 200405s 0 0 eng d | ||
022 | _a0168-8510 | ||
024 | 7 |
_a10.1016/j.healthpol.2003.07.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLexchin, Joel | |
245 | 0 | 0 |
_aThe effect of generic competition on the price of brand-name drugs. _h[electronic resource] |
260 |
_bHealth policy (Amsterdam, Netherlands) _cApr 2004 |
||
300 |
_a47-54 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
650 | 0 | 4 |
_aDrug Costs _xstandards |
650 | 0 | 4 |
_aDrug Industry _xeconomics |
650 | 0 | 4 |
_aDrug Prescriptions _xclassification |
650 | 0 | 4 |
_aDrugs, Generic _xeconomics |
650 | 0 | 4 | _aEconomic Competition |
650 | 0 | 4 | _aFormularies as Topic |
650 | 0 | 4 |
_aGovernment Programs _xeconomics |
650 | 0 | 4 | _aHealth Services Research |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsurance, Pharmaceutical Services _xeconomics |
650 | 0 | 4 | _aOntario |
650 | 0 | 4 | _aPatents as Topic |
650 | 0 | 4 |
_aPrivate Sector _xeconomics |
650 | 0 | 4 |
_aPublic Sector _xeconomics |
773 | 0 |
_tHealth policy (Amsterdam, Netherlands) _gvol. 68 _gno. 1 _gp. 47-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.healthpol.2003.07.007 _zAvailable from publisher's website |
999 |
_c14751237 _d14751237 |